Adrenomyeloneuropathy Clinical Trials
3 recruiting trials for Adrenomyeloneuropathy. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Adrenomyeloneuropathy clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Children's Hospital of Philadelphia (1), Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1), Assistance Publique - Hôpitaux de Paris (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Home exercise (behavioral, 1 trial), followed by Blood sample collection.
Track Adrenomyeloneuropathy trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
The Myelin Disorders Biorepository Project
The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and...
Home Exercise for Individuals with Neurodegenerative Disease
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset...
This study is a national, non-randomized, open-label, multi-site with minimal risk study in adult with adrenomyeloneuropathy (AMN), childhood and adult subjects with cerebral ALD...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Adrenomyeloneuropathy, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Adrenomyeloneuropathy, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Adrenomyeloneuropathy, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.